loxapine 25 MG Oral Capsule
INDICATIONS AND USAGE Loxapine capsules are indicated for the treatment of schizophrenia. The efficacy of loxapine in schizophrenia was established in clinical studies which enrolled newly hospitalized and chronically hospitalized acutely ill schizophrenic patients as subjects.
Actavis Pharma, Inc.
CAPSULE Watson 371 25 mg
Watson 371 25 mg CAPSULE
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
LOXAPINE capsules, USP are available in the following strengths:
LOXAPINE succinate, USP 6.8 mg equivalent to 5 mg
LOXAPINE, black ink, hard shell, opaque, with a white body and cap, printed with “ Watson 369 ” on one half and “ 5 mg ” on the other, are supplied in bottles of 100.
LOXAPINE succinate, USP 13.6 mg equivalent to 10 mg
LOXAPINE, black ink, hard shell, opaque, with a white body and yellow cap, printed with “ Watson 370 ” on one half and “ 10 mg ” on the other, are supplied in bottles of 100.
LOXAPINE succinate, USP 34.0 mg equivalent to 25 mg
LOXAPINE, black ink, hard shell, opaque, with a white body and green cap, printed with “ Watson 371 ” on one half and “ 25 mg ” on the other, are supplied in bottles of 100.
LOXAPINE succinate, USP 68.1 mg equivalent to 50 mg
LOXAPINE, black ink, hard shell, opaque, with a white body and blue cap, printed with “ Watson 372 ” on one half and “ 50 mg ” on the other, are supplied in bottles of 100. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, child-resistant container. Manufactured by: Watson Pharma Private Limited Verna, Salcette Goa 403 722 INDIA Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA Revised: December 2016
More pills like CAPSULE Watson 371 25 mg